Latisse (Bimatoprost .03% Opthalmic Solution) for the Treatment of Hypotrichosis of the Eyebrows: Latisse Versus Placebo

Inclusion Criteria: * Outpatient, female/male subjects of any race, 18-75 years of age. * Subjects of childbearing potential must have a negative urine pregnancy test result at Baseline and practice a reliable method of contraception throughout the study * Patients with hypotrichosis (thinning) of the eyebrows with a GEyA score of 1 or 2. * Patient agrees to abstain from any treatment to the eyebrows including: waxing, plucking, threading, laser hair removal, and/or bleaching (excluding the glabella region). * Able to understand the requirements of the study and sign Informed Consent/HIPAA Authorization forms. * Written informed consent and written authorization for use or release of health and research information obtained. * Willing to complete all required study visits, procedures, and evaluations including photography. Exclusion Criteria: * Subjects who are pregnant (positive urine pregnancy test), planning to become pregnant, breast-feeding, or who are of childbearing potential and not practicing a reliable method of birth control. * Patients with any uncontrolled systemic disease * Patient with any known disease or abnormality of the eyebrows including eczema and seborrheic dermatitis * Patients with known or suspected trichotillomania disorder * Patients with a history of glaucoma and/or increased ocular pressure * Patients who are currently using an IOP-lowering prostaglandin analog (including Lumigan) * Patients with a known hypersensitivity to bimatoprost or any other ingredient in Latisse * Previous cosmetic surgery to the upper face (e.g., periorbital surgery, brow lift, eyelid or eyebrow surgery, etc.). * Patients with permanent eye and/or eyebrow make-up * Any eyebrow tint or dye applications within 2 months prior to study entry * Any planned facial cosmetic procedure that would interfere with the evaluation of the eyebrows * Participation in another investigational drug or device study within the last 30 days